Increased expression of Down Syndrome Cell Adhesion Molecule (Dscam) is implicated in the pathogenesis of brain disorders such as Down syndrome (DS) and fragile X syndrome (FXS). Here, we show that the cellular defects caused by dysregulated Dscam levels can be ameliorated by genetic and pharmacological inhibition of Abelson kinase (Abl) both in Dscam-overexpressing neurons and in a Drosophila model of fragile X syndrome. This study offers Abl as a potential therapeutic target for treating brain disorders associated with dysregulated Dscam expression. DOI: http://dx.doi.org/10.7554/eLife.05196.001
Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
Gabriella R. Sterne,Jung Hwan Kim,Bing Ye
Published 2015 in eLife
ABSTRACT
PUBLICATION RECORD
- Publication year
2015
- Venue
eLife
- Publication date
2015-05-19
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-46 of 46 references · Page 1 of 1
CITED BY
Showing 1-33 of 33 citing papers · Page 1 of 1